Category: Alzheimer's Disease
Alzheimer's Disease market research reports by BCC Research
-
Disease-Modifying Therapies for Alzheimer’s Disease: Global Markets
Report Scope Currently, the disease-modifying therapies (DMTs) market for Alzheimer’s disease (AD) is in its early stage of development, as the first DMT for AD (lecanemab) was granted full approval by the U.S. FDA in July 2023. Several DMTs are in late-stage (phase 2 and above) clinical trials. If ... Read More
-
Alzheimer's Disease Therapeutics and Diagnostics: Global Markets
Alzheimer's Disease Therapeutics and Diagnostics: Global Markets Report Scope This report focuses on the global market for Alzheimer’s disease (AD) diagnostics and therapeutics, offering an updated review of this rapidly emerging market. In this report, the diagnostic market covers only biomarker te ... Read More
-
Emerging Tools for Alzheimer's Disease
Emerging Tools for Alzheimer's Disease Report Scope: The report provides an overview of AD, and the current diagnostic methods. The report explains the need for emerging tools for the early detection of the disease. Tools that have been approved are discussed, as well as tools in the development pha ... Read More
Research Assistance
